Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2025 Filed Jul 2, 2025 18:21 UTC |
Smith GordonDirector
|
GrantRestricted Stock Units · Derivative | 136 | $242.82 | $33,022.84 |
DisclosureSEC source: 0001062993-25-012434 · form4.xml · derivative · entry 3 Smith Gordon · CIK 0001311487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254 Underlying: Humana Common · 136 shares Expires not disclosed F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 15:53 UTC |
Feinberg David TDirector
|
GrantRestricted Stock Units · Derivative | 76 | $242.82 | $18,453.94 |
DisclosureSEC source: 0001062993-25-012426 · form4.xml · derivative · entry 3 Feinberg David T · CIK 0001486426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569 Underlying: Humana Common · 76 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| May 14, 2025 Filed May 16, 2025 20:48 UTC |
Rechtin James A.President & CEO
|
PurchaseHumana Common | 6,530 | $229.25 | $1,496,983.56 |
DisclosureSEC source: 0001062993-25-009705 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 30,474 F7 · price: Average price of shares purchased in reported transaction. F6 · balance_after: Includes 21,761 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 17:46 UTC |
Smith GordonDirector
|
GrantRestricted Stock Units · Derivative | 118 | $263.88 | $31,137.25 |
DisclosureSEC source: 0001062993-25-006787 · form4.xml · derivative · entry 3 Smith Gordon · CIK 0001311487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118 Underlying: Humana Common · 118 shares Expires not disclosed F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 17:45 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 345 | $263.88 | $91,036.88 |
DisclosureSEC source: 0001062993-25-006786 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,645 Underlying: Humana Common · 345 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 17:44 UTC |
Feinberg David TDirector
|
GrantRestricted Stock Units · Derivative | 66 | $263.88 | $17,415.75 |
DisclosureSEC source: 0001062993-25-006785 · form4.xml · derivative · entry 3 Feinberg David T · CIK 0001486426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 493 Underlying: Humana Common · 66 shares Expires not disclosed F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| March 27, 2025 Filed Mar 31, 2025 11:57 UTC |
Renaudin George IIPresident, Insurance
|
OtherPhantom Stock Units · Derivative | 5 | $270.38 | $1,351.90 |
DisclosureSEC source: 0001062993-25-006535 · form4.xml · derivative · entry 7 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 170 Underlying: Humana Common · 5 shares Expires not disclosed F8 · security: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price. F8 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price. F8 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price. F8 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price. F8 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of March 27, 2025 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 20:11 UTC |
Dintenfass DavidPresident, Enterprise Growth
|
GrantHumana Common | 4,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003420 · form4.xml · nonDerivative · entry 2 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,234 F2 · balance_after: Includes 13,234 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 18:49 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
GrantHumana Common | 3,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003392 · form4.xml · nonDerivative · entry 3 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,717 F12 · balance_after: Includes 4,178 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 18:11 UTC |
Renaudin George IIPresident, Insurance
|
GrantHumana Common | 4,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003390 · form4.xml · nonDerivative · entry 3 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,702 F7 · balance_after: Includes 11,165 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 18:08 UTC |
Ventura Joseph CChief Legal Officer
|
GrantHumana Common | 4,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003388 · form4.xml · nonDerivative · entry 3 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,267 F9 · balance_after: Includes 8,296 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:21 UTC |
Mehta JapanChief Information Officer
|
GrantHumana Common | 3,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003657 · form4.xml · nonDerivative · entry 1 Mehta Japan · CIK 0002053625 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,628 F1 · balance_after: Includes 8,628 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 20:50 UTC |
Shetty Sanjay KPresident, CenterWell
|
GrantHumana Common | 4,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003616 · form4.xml · nonDerivative · entry 1 Shetty Sanjay K · CIK 0001969331 · President, CenterWell 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,566 F5 · balance_after: Includes 10,786 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 20:40 UTC |
O'Hara Michelle A.Chief Human Resources Officer
|
GrantHumana Common | 4,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003612 · form4.xml · nonDerivative · entry 1 O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,266 F1 · balance_after: Includes 11,266 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 15:19 UTC |
Rechtin James A.President & CEO
|
GrantHumana Common | 19,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003577 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 23,944 F6 · balance_after: Includes 21,761 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 14:58 UTC |
Felter John-Paul W.SVP, Chief Accting Off & Cont.
|
GrantHumana Common | 876 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003569 · form4.xml · nonDerivative · entry 1 Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,767 F4 · balance_after: Includes 1,203 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 14:38 UTC |
Mellet CelesteChief Financial Officer
|
GrantHumana Common | 6,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003567 · form4.xml · nonDerivative · entry 1 Mellet Celeste · CIK 0001748812 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,676 F1 · balance_after: Includes 29,676 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 20:11 UTC |
Dintenfass DavidPresident, Enterprise Growth
|
Tax withholdingHumana Common | 1,175 | $258.58 | $303,825.63 |
DisclosureSEC source: 0001062993-25-003420 · form4.xml · nonDerivative · entry 1 Dintenfass David · CIK 0002010288 · President, Enterprise Growth 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,874 F3 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 2/21/25. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 18:49 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Tax withholdingHumana Common | 905 | $258.58 | $234,010.38 |
DisclosureSEC source: 0001062993-25-003392 · form4.xml · nonDerivative · entry 2 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,447 F11 · shares: Disposition reported represents shares withheld for payment of tax liability on Performance Stock units vested on 2/21/25. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 18:49 UTC |
Agrawal VishalChief Strat & Corp Dev Officer
|
Exercise / conversionHumana Common | 1,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003392 · form4.xml · nonDerivative · entry 1 Agrawal Vishal · CIK 0001761461 · Chief Strat & Corp Dev Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Includes Performance Stock Units not required to be reported until vest. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 18:11 UTC |
Renaudin George IIPresident, Insurance
|
Tax withholdingHumana Common | 300 | $258.58 | $77,572.50 |
DisclosureSEC source: 0001062993-25-003390 · form4.xml · nonDerivative · entry 2 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,186 F9 · shares: Shares disposed of represent payment for tax liability for Performance Stock units vested on 2/21/25. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 18:11 UTC |
Renaudin George IIPresident, Insurance
|
Exercise / conversionHumana Common | 732 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003390 · form4.xml · nonDerivative · entry 1 Renaudin George II · CIK 0001964078 · President, Insurance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · shares: Includes Performance Stock Units not required to be reported until vest. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 18:08 UTC |
Ventura Joseph CChief Legal Officer
|
Tax withholdingHumana Common | 1,065 | $258.58 | $275,382.38 |
DisclosureSEC source: 0001062993-25-003388 · form4.xml · nonDerivative · entry 2 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,829 F10 · shares: Shares disposed of represent payment for tax liability on Performance Stock Units vested on 2/21/25. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 18:08 UTC |
Ventura Joseph CChief Legal Officer
|
Exercise / conversionHumana Common | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003388 · form4.xml · nonDerivative · entry 1 Ventura Joseph C · CIK 0001768291 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · shares: Includes Performance Stock Units not required to be reported until vest. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 15:26 UTC |
Mellet CelesteChief Financial Officer
|
GrantHumana Common | 23,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002637 · form4.xml · nonDerivative · entry 1 Mellet Celeste · CIK 0001748812 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,291 F1 · balance_after: Includes 23,291 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 14:58 UTC |
Mehta JapanChief Information Officer
|
GrantHumana Common | 5,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002633 · form4.xml · nonDerivative · entry 1 Mehta Japan · CIK 0002053625 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,046 F1 · balance_after: Includes 5,046 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 16:47 UTC |
Rechtin James A.President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000655 · form4.xml · derivative · entry 5 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,366 Underlying: Humana Common · 2,182 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3). F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 16:47 UTC |
Rechtin James A.President & CEO
|
Tax withholdingHumana Common | 978 | $264.68 | $258,857.04 |
DisclosureSEC source: 0001062993-25-000655 · form4.xml · nonDerivative · entry 2 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 4,907 F7 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 1/8/25. F6 · balance_after: Includes 2,724 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 16:47 UTC |
Rechtin James A.President & CEO
|
Exercise / conversionHumana Common | 2,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000655 · form4.xml · nonDerivative · entry 1 Rechtin James A. · CIK 0002006065 · President & CEO 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:48 UTC |
Klevorn Marcy SDirector
|
GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000214 · form4.xml · derivative · entry 2 Klevorn Marcy S · CIK 0001692367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,005 Underlying: Humana Common · 783 shares Expires not disclosed F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:46 UTC |
Frederick Wayne A.I.Director
|
GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000210 · form4.xml · derivative · entry 2 Frederick Wayne A.I. · CIK 0001802241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,408 Underlying: Humana Common · 783 shares Expires not disclosed F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 18:42 UTC |
DAMELIO FRANK ADirector
|
GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000103 · form4.xml · derivative · entry 2 DAMELIO FRANK A · CIK 0001194004 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,060 Underlying: Humana Common · 783 shares Expires not disclosed F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 18:29 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000099 · form4.xml · derivative · entry 2 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,861 Underlying: Humana Common · 783 shares Expires not disclosed F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 18:26 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000097 · form4.xml · derivative · entry 2 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,034 Underlying: Humana Common · 783 shares Expires not disclosed F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 18:09 UTC |
Smith GordonDirector
|
GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000091 · form4.xml · derivative · entry 2 Smith Gordon · CIK 0001311487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 783 Underlying: Humana Common · 783 shares Expires not disclosed F2 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 15:53 UTC |
Bono Raquel C.Director
|
GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000058 · form4.xml · derivative · entry 2 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,408 Underlying: Humana Common · 783 shares Expires not disclosed F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 15:30 UTC |
Garratt John WDirector
|
GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000054 · form4.xml · derivative · entry 2 Garratt John W · CIK 0001646121 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,163 Underlying: Humana Common · 783 shares Expires not disclosed F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 15:12 UTC |
Feinberg David TDirector
|
GrantRestricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000050 · form4.xml · derivative · entry 2 Feinberg David T · CIK 0001486426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,593 Underlying: Humana Common · 783 shares Expires not disclosed F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 15:10 UTC |
SMITH BRAD DDirector
|
GrantHumana Common | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000048 · form4.xml · nonDerivative · entry 1 SMITH BRAD D · CIK 0001284323 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,169 F4 · balance_after: Includes 783 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 15:08 UTC |
Mesquita Jorge S.Director
|
GrantHumana Common | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000046 · form4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,361 F1 · balance_after: Includes 783 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. F1 · ownership.nature: Includes 783 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 18:33 UTC |
O'Hara Michelle A.Chief Human Resources Officer
|
GrantHumana Common | 7,061 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000101 · form4.xml · nonDerivative · entry 1 O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,061 F1 · balance_after: Includes 7,061 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:48 UTC |
Klevorn Marcy SDirector
|
GrantRestricted Stock Units · Derivative | 17 | $254.93 | $4,333.81 |
DisclosureSEC source: 0001062993-25-000214 · form4.xml · derivative · entry 3 Klevorn Marcy S · CIK 0001692367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25 Underlying: Humana Common · 17 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:46 UTC |
Frederick Wayne A.I.Director
|
GrantRestricted Stock Units · Derivative | 23 | $254.93 | $5,863.39 |
DisclosureSEC source: 0001062993-25-000210 · form4.xml · derivative · entry 3 Frederick Wayne A.I. · CIK 0001802241 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38 Underlying: Humana Common · 23 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 18:29 UTC |
KATZ KARENDirector
|
GrantRestricted Stock Units · Derivative | 38 | $254.93 | $9,687.34 |
DisclosureSEC source: 0001062993-25-000099 · form4.xml · derivative · entry 4 KATZ KAREN · CIK 0001157619 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75 Underlying: Humana Common · 38 shares Expires not disclosed F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 18:26 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 673 | $254.93 | $171,567.89 |
DisclosureSEC source: 0001062993-25-000097 · form4.xml · derivative · entry 4 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,300 Underlying: Humana Common · 673 shares Expires not disclosed F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 18:26 UTC |
HILZINGER KURT JDirector
|
GrantRestricted Stock Units · Derivative | 565 | $254.93 | $144,035.45 |
DisclosureSEC source: 0001062993-25-000097 · form4.xml · derivative · entry 3 HILZINGER KURT J · CIK 0001191504 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,753 Underlying: Humana Common · 565 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d). Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 18:11 UTC |
Diamond Susan MChief Financial Officer
|
OtherPhantom Stock Units · Derivative | 1 | $260.73 | $260.73 |
DisclosureSEC source: 0001062993-25-000093 · form4.xml · derivative · entry 9 Diamond Susan M · CIK 0001782445 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote. Disclosed balance after: 332 Underlying: Humana Common · 1 shares Expires not disclosed F10 · security: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024. F10 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024. F10 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024. F10 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024. F10 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of December 31, 2024 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivalents, allocated the last business day of the quarter. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of December 31, 2024. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 15:53 UTC |
Bono Raquel C.Director
|
GrantRestricted Stock Units · Derivative | 23 | $254.93 | $5,863.39 |
DisclosureSEC source: 0001062993-25-000058 · form4.xml · derivative · entry 3 Bono Raquel C. · CIK 0001823759 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38 Underlying: Humana Common · 23 shares Expires not disclosed F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 15:51 UTC |
Huval Timothy S.Chief Administrative Officer
|
GiftHumana Common | 1,070 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-000056 · form4.xml · nonDerivative · entry 2 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,111 F11 · shares: Shares disposed of represent gift/charitable donation in which no value was received in return. F9 · balance_after: Includes 3,813 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 15:51 UTC |
Huval Timothy S.Chief Administrative Officer
|
SaleHumana Common | 3,703 | $256.26 | $948,925.23 |
DisclosureSEC source: 0001062993-25-000056 · form4.xml · nonDerivative · entry 1 Huval Timothy S. · CIK 0001565717 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,181 F10 · price: All shares sold at reported price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.